Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Adjusting your budget at the right time can significantly improve your financial situation. Learn the key moments when adjustments are necessary.
18,051 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
An executive sale of shares often sparks questions. This article unpacks what cheesecake factory sells $328000 means ...
Nike stock has fallen significantly from its 52-week peak, even as the CEO buys shares. This guide explains what the ...
Unlock actionable takeaways from the 2026 earnings call transcript for IFS. This guide translates the quarter’s numbe...
A top tech entrepreneur’s possible pivot toward natural gas could ripple through energy markets. This guide breaks do...
Investors eye the Fennec Q1 2026 call to gauge milestones, cash runway, and potential catalysts. This guide breaks do...
As 2026 unfolds, investors are weighing which bank stocks offer durable growth and solid risk controls. This guide br...
Unum Group operates in the steady world of employer benefits and personal protection. If three key trends line up—und...
A practical guide to understanding finvolution (finv) 2026 earnings, what to watch in the Q1 transcript, and how to p...
A new funding framework is here. The housing 21st century brings new loan options and smarter ways to build and prese...
A new wave of skepticism surrounds the Fed after a high-profile critique from a former governor. This piece explains ...
Cavco stock rose about 9% over the past year even as a large fund pulled roughly $12 million in Cavco shares. This ar...